A Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase 2 Study Of Ganitumab Or Rilotumumab With Platinum-Based Chemotherapy As First-Line Treatment For Extensive-Stage Small-Cell Lung Cancer (Sclc)
JOURNAL OF THORACIC ONCOLOGY（2013）
关键词
rilotumumab,Small-cell lung cancer,phase 2,ganitumab
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要